{"id":"W1925049370","doi":"10.1016/j.jalz.2015.05.008","title":"The Worldwide Alzheimer's Disease Neuroimaging Initiative: An update","year":2015,"lang":"en","type":"review","venue":"Alzheimer s & Dementia","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; Avid Radiopharmaceuticals; Chugai Pharmaceutical; University of California, San Diego; Genentech; National Institutes of Health; Fleni; IXICO; Servier; Shionogi; Astellas Pharma; Eisai; Ministry of Economy, Trade and Industry; Daiichi-Sankyo; Northern California Institute for Research and Education; Pfizer; Biogen; BioClinica; Synarc; European Federation of Pharmaceutical Industries and Associations; Medpace; Bristol-Myers Squibb; Eli Lilly and Company; National Health and Medical Research Council; AstraZeneca; F. Hoffmann-La Roche; Australian Government; Novartis Pharmaceuticals Corporation; Alzheimer's Association; Amorfix Life Sciences; Alzheimer's Drug Discovery Foundation; Bayer HealthCare; European Commission; Meso Scale Diagnostics; National Institute on Aging; Commonwealth Scientific and Industrial Research Organisation; Foundation for the National Institutes of Health","keywords":"Alzheimer's Disease Neuroimaging Initiative; Neuroimaging; Data sharing; Dementia; Medicine; Disease; Psychiatry; Internal medicine; Pathology; Alternative medicine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004429694,0.001581102,0.003728775,0.0130637,0.0004391692,0.002360002,0.00247831,0.002072255,0.006372227],"category_scores_gemma":[0.006233462,0.0007446436,0.002259718,0.01188143,0.0006399833,0.003754531,0.001598478,0.002293684,0.002385615],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002444701,"about_ca_system_score_gemma":0.007611325,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006808357,"about_ca_topic_score_gemma":0.01603751,"domain_scores_codex":[0.9987124,0.0002467016,0.0003944055,0.0001096807,0.0004563562,0.00008047793],"domain_scores_gemma":[0.9961588,0.001474887,0.0007970321,0.00007122035,0.001272165,0.0002259457],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001446596,0.00006397769,0.0004636542,0.07423165,0.0004119033,0.0001672946,0.0001279693,0.0001174094,0.0001784629,0.001799519,0.1272557,0.7950377],"study_design_scores_gemma":[0.00006371786,0.00006897057,0.001846876,0.05415701,0.001088717,0.0009801999,0.000104328,0.00005118873,0.00007597987,0.0009830223,0.9405493,0.00003071887],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004387108,0.9984514,0.00002966267,0.0006634198,0.0002878809,0.00001414785,0.0001006753,0.000006205755,0.0004027008],"genre_scores_gemma":[0.0002474806,0.9986694,0.0001477199,0.0003622845,0.0002068874,0.00002097239,0.0001812068,0.000002089482,0.0001620108],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0130637,"threshold_uncertainty_score":0.02342677,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1046935646509278,"score_gpt":0.4009590609403609,"score_spread":0.2962654962894332,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}